cAMP protection of pancreatic cancer cells against apoptosis induced by ERK inhibition

Biochemical and Biophysical Research Communications

Volumn 285, Issue 2, 2001, Pages 207-216

  Boucher, Marie Josée ^a   Duchesne, Cathia ^a   Rivard, Nathalie ^a   Lainé, Jean ^b   Morisset, Jean ^b  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Apoptosis; Bcl 2 homologs; cAMP; Caspases; Cell cycle; ERK; Pancreatic cancer cells; Survival

Indexed keywords

CASPASE 3; CASPASE 6; CASPASE 8; CASPASE 9; CYCLIC AMP; FORSKOLIN; ISOBUTYLMETHYLXANTHINE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL;

EID: 0034816092     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.5147     Document Type: Article

References (65)

1. A matter of life and cell death
2. Apoptotic pathways: The roads to ruin
3. Role of proto-oncogene activation in carcinogenesis
4. Oncogenes and signal transduction
5. Apoptosis: Molecular regulation of cell death
6. Pancreatic cancer: The potential clinical relevance of alterations in growth factors and their receptors
7. L and Mcl-1 and promotes survival of human pancreatic cancer cells
8. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and-independent mechanisms
9. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′, 5′-monophosphate
10. Inhibition by cAMP of Ras-dependent activation of Raf
11. Increasing cAMP attenuates activation of mitogen-activated protein kinase
12. The role of cyclic AMP in cell proliferation: A critical assessment of evidence
13. Cyclic AMP inhibits mitogen-induced DNA synthesis in hamster fibroblasts, regardless of the signaling pathway involved
14. Elevation of intracellular cyclic adenosine monophosphate inhibits the epidermal growth factor signal transduction pathway and cellular growth in pancreatic adenocarcinoma cell lines
15. Cyclic AMP induces inhibition of cyclin A expression and growth arrest in human hepatoma cells
16. Type I cAMP-dependent protein kinase delays apoptosis in human neutrophils at a site upstream of caspase-3
17. Prevention of cycloheximide-induced apoptosis in hepatocytes by adenosine and caspase inhibitors
18. Cyclic nucleotides suppress tumor necrosis factor α-mediated apoptosis by inhibiting caspase activation and cytochrome c release in primary hepatocytes via a mechanism independent of Akt activation
19. Signal integration at the level of protein kinases, protein phosphatases and their substrates
20. SHC adaptor proteins are key transducers of mitogenic signaling mediated by the G protein-coupled thrombin receptor
21. A simplification of the protein assay method of Lowry et al. which is more generally applicable
22. MAP kinase cascade is required for p27 down-regulation and S-phase entry in fibroblasts and epithelial cells
23. p21-induced cycle arrest in G1 protects cells from apoptosis induced by UV-irradiation or RNA polymerase II blockage
24. Forskolin: Its biological and chemical properties
25. Isobutyl-methylxanthine stimulates adenylate cyclase by blocking the inhibitory regulatory protein
26. Inhibitors of mammalian G1-cyclin-dependent kinases
27. Cyclin E controls S phase progression and its down-regulation during Drosophila embryogenesis is required for the arrest of cell proliferation
28. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE
29. Caspases: Intracellular signaling by proteolysis
30. Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidyl 3-kinase/Akt and mitogen-activated protein kinase pathways
31. Apoptosis suppression by Raf-1 and MEK1 requires MEK- and phosphatidyl 3-kinase-dependent signals
32. Specificity in the cAMP/PKA signaling pathway. Differential expression, regulation and subcellular localization of subunits of PKA
33. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-13-3 not Bcl-X(L)
34. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A
35. CREB: A stimulus-induced transcription factor activated by a diverse array of extracellular signals
36. Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A
37. Role of cyclic nucleotides in growth control
38. Regulation of Ras-mediated signaling: More than one way to skin a cat
39. Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts
40. Kip1) of cyclin-dependent kinase 4 activation
41. Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis
42. CDK inhibitors: Positive and negative regulators of G1-phase progression
43. Kip1 by cDNA antisens suppresses quiescence (G0 state) in fibroblasts
44. An analysis of Mek1 signaling in cell proliferation and transformation
45. mapk are required for fibroblast proliferation
46. Inhibition of tumor necrosis factor-alpha induced neutrophil apoptosis by cyclic AMP: Involvement of caspase cascade
47. cAMP increasing agents attenuate the generation of apoptosis by etoposide in promonocytic leukemia cells
48. Modulation of nitric oxide-induced apoptotic death of HL-60 cells by protein kinase C and protein kinase A through mitogen-activated protein kinases and CPP32-like protease pathways
49. Fas/APO-1(CD95)-induced apoptosis of primary hepatocytes is inhibited by cAMP
50. Cyclic adenosine monophosphate-mediated protection against bile acid-induced apoptosis in cultured rat hepatocytes
51. Nitric oxide delays the death of trophic factor-deprived PC12 cells and sympathetic neurons by a cGMP-mediated mechanism
52. Cyclic AMP mediates endothelial protection by nitric oxide
53. Activation of cAMP signaling transiently inhibits apoptosis in vascular smooth muscle cells in a site upstream of caspase-3
54. Expression of the antiapoptotic MCL1 gene product is regulated by a mitogen activated protein kinase-mediated pathway triggered through microtubule disruption and protein kinase C
55. Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3β
56. Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons
57. Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis
58. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death
59. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
60. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signaling in intact cells
61. Interleukin 3-dependent survival by the Akt protein kinase
62. Cytokine-induced protein kinase B activation and Bad phosphorylation do not correlate with cell survival of hematopoietic cells
63. Antiapoptotic signaling in LNCaP prostate cancer cells: A survival signaling pathway independent of phosphatidylinositol 3′-kinase and Akt/protein kinase B
64. Akt-dependent and-independent survival signaling pathways utilized by insulin-like growth factor I
65. Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/Akt: Involvement of MEK upstream of Bad phosphorylation